Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
- Status
- COMPLETED
- Phase
- N/A
Cognitive Training and Brain Stimulation in Patients With Post-COVID-19 Cognitive Impairment
- Status
- COMPLETED
- Phase
- NA
Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations
- Status
- UNKNOWN
- Phase
- N/A
The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients
- Status
- COMPLETED
- Phase
- PHASE4
Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19
- Status
- COMPLETED
- Phase
- NA
Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1
Comparison of COVID-19 and H1N1 Influenza Pneumonia
- Status
- COMPLETED
- Phase
- N/A
MP1032 Treatment in Patients With Moderate to Severe COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)
- Status
- TERMINATED
- Phase
- PHASE2
In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection
- Status
- COMPLETED
- Phase
- NA
Novel Experimental COVID-19 Therapies Affecting Host Response
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3